Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
Kahn Brothers Group 13F holdings
Kahn Brothers Group's Portfolio
- Portfolio value:
- $497.95M≈
- # of securities:
- 50
- Reported for:
- 30 Jun 2025 (Q2)
- Latest filing date:
- 14 Aug 2025
What stocks did Kahn Brothers Group own in 2025 Q2?
What was Kahn Brothers Group's 2025 Q2 portfolio?
Kahn Brothers Group has disclosed a total of 50 security holdings in their (2025 Q2) SEC 13F filing(s) with portfolio value of $497,945,476.
Kahn Brothers Group's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Kahn Brothers Group's original 13F reports (2025 Q2) are the official SEC institutional disclosure documents covering all reported equity positions.
50 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Citigroup Inc
|
15.16%
|
886,688
|
$85.12
|
+55.13%($132.05)
|
$75,474,882
|
2013 Q2 or earlier
|
≈ 12.25+ years
|
Common Stock
|
+1.13% (+9.88K)
|
+0.17%
|
|
|
|
Bayer AG PK
|
10.19%
|
6,728,903
|
$7.54
|
+73.61%($13.09)
|
$50,734,969
|
2023 Q4
|
≈ 1.75 years
|
Depositary Receipt
|
+2.36% (+155.21K)
|
+0.24%
|
|
|
|
Walt Disney Company
|
9.77%
|
392,450
|
$124.01
|
-23.16%($95.29)
|
$48,667,724
|
2024 Q1
|
≈ 1.50 years
|
Common Stock
|
+12.72% (+44.28K)
|
+1.1%
|
|
|
|
Flagstar Financial, Inc
|
9.20%
|
4,321,165
|
$10.60
|
+30.90%($13.88)
|
$45,804,349
|
2013 Q2 or earlier
|
≈ 12.25+ years
|
Common Stock
|
+2.47% (+104.18K)
|
+0.22%
|
|
|
|
Merck & Company Inc
|
7.80%
|
490,465
|
$79.16
|
+65.87%($131.30)
|
$38,825,234
|
2013 Q2 or earlier
|
≈ 12.25+ years
|
Common Stock
|
-0.37% (-1.81K)
|
-0.03%
|
|
|
|
BP PLC-SPONS ADR
|
6.79%
|
1,129,372
|
$29.93
|
+46.39%($43.82)
|
$33,802,103
|
2013 Q2 or earlier
|
≈ 12.25+ years
|
Depositary Receipt
|
-1.79% (-20.6K)
|
-0.12%
|
|
|
|
Organon & Co
|
6.78%
|
3,490,150
|
$9.68
|
+39.93%($13.54)
|
$33,784,652
|
2021 Q2
|
≈ 4.25 years
|
Common Stock
|
+39.98% (+996.77K)
|
+1.94%
|
|
|
|
IDT Corp
|
5.44%
|
396,564
|
$68.32
|
-5.64%($64.47)
|
$27,093,252
|
2013 Q2 or earlier
|
≈ 12.25+ years
|
Common Stock
|
+8.49% (+31.03K)
|
+0.43%
|
|
|
|
Bristol-Myers Squibb Company
|
5.12%
|
550,683
|
$46.29
|
+34.17%($62.10)
|
$25,491,116
|
2013 Q2 or earlier
|
≈ 12.25+ years
|
Common Stock
|
-7.82% (-46.74K)
|
-0.44%
|
|
|
|
GlaxoSmithKline PLC ADR
|
5.09%
|
659,872
|
$38.40
|
+33.46%($51.25)
|
$25,339,084
|
2014 Q3
|
≈ 11.00 years
|
Depositary Receipt
|
-19.75% (-162.36K)
|
-1.26%
|
|
Completely sold out
10 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
VIEWRAY INC
|
-353,744
|
|
2019 Q2
|
≈ 6.00 years
|
|
|
|
Hologic Inc
|
-19,757
|
-0.25%
|
2013 Q2 or earlier
|
≈ 12.00+ years
|
|
|
|
Capital One Financial Corp
|
-1,971
|
-0.07%
|
2025 Q1
|
≈ 0.25 years
|
|
|
|
Cigna Corp
|
-841
|
-0.06%
|
2024 Q1
|
≈ 1.25 years
|
|
|
|
Lifeway Foods Inc
|
-10,000
|
-0.05%
|
2019 Q2
|
≈ 6.00 years
|
|
|
|
Weyco Group Inc
|
-7,197
|
-0.04%
|
2025 Q1
|
≈ 0.25 years
|
|
|
|
NAM TAI ELECTRONICS INC-W/I
|
-36,040
|
-0.04%
|
2022 Q4
|
≈ 2.50 years
|
|
|
|
Garrett Motion Inc
|
-12,318
|
-0.02%
|
2024 Q1
|
≈ 1.25 years
|
|
|
|
Trinity Place Holdings Inc
|
-591,466
|
-0.01%
|
2013 Q2 or earlier
|
≈ 12.00+ years
|
|
|
|
IDW Media Holdings Inc
|
-36,419
|
-0%
|
2015 Q3
|
≈ 9.75 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.